Botanix Pharmaceuticals | WA Innovation Ecosystem Navigator
About Botanix Pharmaceuticals
Botanix Pharmaceuticals is an ASX-listed biopharmaceutical company specializing in the development and commercialization of innovative dermatology and antimicrobial products. The company's lead product, Sofdra® (sofpironium topical gel), is approved by the US FDA for the treatment of skin diseases. With a global team and headquarters in both Australia and the USA, Botanix aims to address common yet underserved skin conditions using advanced drug delivery technologies.
Ecosystem activity
2019
1 milestone
November
Received $50K grant from
2018
1 milestone
August
Received $50K grant from
Is this your organisation?
Claim this profile to add your story, team and milestones.